GE Vernova Inc.
NYSE:GEVRenewable Utilities
+$46.41 today
- Market cap
- $204.39B
- Beta
- 1.04
- P/E (TTM)
- 31.4
- EPS (TTM)
- $34.85
- Dividend yield
- 0.16%
Volume 3.14M
Average 2.67M
GEV Pre-Tax Margin
Income before tax as a percentage of revenue.
GE Vernova Inc.NYSE: GEV
Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026
Pre-tax margin widens to 8.3%
Pre-tax margin was 8.3% in Q2 FY2026, up 1.3 pp from a year earlier. On a trailing-twelve-month basis it was 19.0%, up 13.7 pp year over year. Over 3 fiscal years it widened by 15.8 pp.
Context
- Pre-tax margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 7.4%
- Year-over-year change
- +0.3pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.4% | +0.3pp |
| FY2024 | 2024-12-31 | 7.1% | +7.5pp |
| FY2023 | 2023-12-31 | -0.4% | +8.0pp |
| FY2022 | 2022-12-31 | -8.3% | -5.7pp |
| FY2021 | 2021-12-31 | -2.6% | — |
Pre-Tax Margin vs competitors
How GEV compares with its peers on the latest reported figures
- GEV's LTM Jun 2026 pre-tax margin of 19.0% is the 3rd highest of the 7 companies compared; the peer median is 17.4%.
- Its year-over-year change of +13.7 pp is the 2nd highest of 7, against a peer median of +0.7 pp.
- Over three fiscal years its change of +15.8 pp compares with a peer median of -1.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 34.6% | +18.4 pp | -1.8 pp | |
| LTM Jun 2026 | 28.2% | -1.9 pp | -2.6 pp | |
| LTM Jun 2026 | 19.0% | +13.7 pp | +15.8 pp | |
| LTM Sep 2026 | 17.4% | +2.6 pp | +16.0 pp | |
| LTM Jun 2026 | 17.4% | -0.8 pp | +2.5 pp | |
INIOINNIO N.V. Ordinary Shares | FY2025 | 7.0% | +2.1 pp | — |
| LTM Sep 2026 | 4.4% | -1.6 pp | -1.8 pp | |
| Peer median (excluding GEV) | 17.4% | +0.7 pp | -1.8 pp | |
Competitors are the stored peer set for GEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 33.01B | 29.65B | 33.24B | 34.94B | 38.07B |
| Cost of Revenue | 28.06B | 26.2B | 28.42B | 28.63B | 30.53B |
| Gross Profit | 4.95B | 3.46B | 4.82B | 6.31B | 7.54B |
| Gross Margin | 15.0% | 11.7% | 14.5% | 18.1% | 19.8% |
| Research & Development | 1.01B | 979M | 896M | 982M | 1.2B |
| Selling, General & Admin | 4.82B | 5.36B | 4.85B | 4.54B | 4.95B |
| Operating Expenses | 5.83B | 6.34B | 5.74B | 5.52B | 6.15B |
| Depreciation & Amortization | 1.18B | 1.8B | 964M | 1.17B | 853M |
| EBITDA | 484M | (526M) | 932M | 3.67B | 3.68B |
| EBITDA Margin | 1.5% | -1.8% | 2.8% | 10.5% | 9.7% |
| Operating Income | (884M) | (2.88B) | (923M) | 787M | 1.39B |
| Operating Margin | -2.7% | -9.7% | -2.8% | 2.3% | 3.6% |
| Interest Income | 71M | 42M | 63M | 186M | 186M |
| Interest Expense | 172M | 151M | 98M | 0 | 0 |
| Other Income / Expenses | 20M | 407M | 793M | 1.71B | 1.44B |
| Income Before Tax | (864M) | (2.47B) | (130M) | 2.5B | 2.83B |
| Pre-Tax Margin | -2.6% | -8.3% | -0.4% | 7.1% | 7.4% |
| Income Tax Expense | (140M) | 248M | 344M | 939M | (2.05B) |
| Net Income | (633M) | (2.74B) | (438M) | 1.55B | 4.88B |
| Net Margin | -1.9% | -9.2% | -1.3% | 4.4% | 12.8% |
| EPS (Basic) | (2.33) | (10.06) | (1.61) | 5.64 | 17.92 |
| EPS (Diluted) | (2.33) | (10.06) | (1.61) | 5.58 | 17.69 |
| Weighted Avg Shares | 272.08M | 272.08M | 272.08M | 275M | 272M |
| Weighted Avg Shares (Diluted) | 272.08M | 272.08M | 272.08M | 278M | 276M |
GE Vernova Inc.
NYSE:GEV
Intrinsic Alpha fair value
Locked
Current Price
$772.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.